Associated Papers
Functional and Biochemical Consequences of Disease Variants in Neurotransmitter Transporters: A Special Emphasis on Folding and Trafficking Deficits.
Bhat S et al.
Pharmacology & Therapeutics, 2021
Homozygous in-frame variant of SCL6A3 causes dopamine transporter deficiency syndrome in a consanguineous family.
Heidari E et al.
Annals of Human Genetics, 2020
SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking.
Bowton E et al.
Translational Psychiatry, 2014
Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder.
Mergy MA et al.
Neurochemistry International, 2014
Defining the blanks--pharmacochaperoning of SLC6 transporters and ABC transporters.
Chiba P et al.
Pharmacological Research, 2014
Genetic influences of dopamine transport gene on alcohol dependence: a pooled analysis of 13 studies with 2483 cases and 1753 controls.
Xu M et al.
Progress in Neuro-psychopharmacology & Biological Psychiatry, 2011
Association between harmful alcohol consumption behavior and dopamine transporter (DAT1) gene polymorphisms in a male Finnish population.
Lind PA et al.
Psychiatric Genetics, 2009
Anomalous dopamine release associated with a human dopamine transporter coding variant.
Mazei-Robison MS et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience, 2008
Genetics of dopamine and its contribution to cocaine addiction.
Haile CN et al.
Behavior Genetics, 2007
Human genetics and pharmacology of neurotransmitter transporters.
Lin Z et al.
Handbook of Experimental Pharmacology, 2006
Expression studies of naturally occurring human dopamine transporter variants identifies a novel state of transporter inactivation associated with Val382Ala.
Mazei-Robison MS et al.
Neuropharmacology, 2005
Human dopamine transporter gene variation: effects of protein coding variants V55A and V382A on expression and uptake activities.
Lin Z et al.
The Pharmacogenomics Journal, 2003
Common human 5' dopamine transporter (SLC6A3) haplotypes yield varying expression levels in vivo.
Drgon T et al.
Cellular and Molecular Neurobiology, 0
SLC6 transporters: structure, function, regulation, disease association and therapeutics.
Pramod AB et al.
Molecular Aspects of Medicine, 0
Select a paper to view details